当前位置：首页 > 文献互助 > 互助详情

Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079)复制

用户Lz2LyWF0h8HA 3小时前 9 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-04-05 14:42:41 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.ygyno.2022.04.011复制

文献链接:复制

其他信息:

上一篇：The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates

下一篇：Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study

互助时间线

2026-03-29 14:43:07 [完结求助]

楼主确认了用户nD5FuGcY3mbX应助的文件是正确的, 求助状态变成 已完结

2026-03-29 14:42:41 [上传文件]

用户nD5FuGcY3mbX上传了文件(pdf 562.64 KB), 求助状态变成 待确认

2026-03-29 14:42:38 [发起求助]

最新发布的求助

Signaling pathways in hepatocellular carcinoma 26分钟前
Implication of the Hedgehog pathway in hepatocellular carcinoma 31分钟前
Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma 39分钟前
The Chobanids of Kastamonu: Politics, Patronage, and Religion in Thirteenth Century Anatolia, (Routledge Studies in the History of Iran and Turkey) 52分钟前
Hedgehog Signaling: Implications in Liver Pathophysiology 1小时前
DOI： 10.1055/a-2187-3382 1小时前
A single-chain fab derived drug conjugate for HER2 specific delivery 1小时前
Droplet-based microfluidics 1小时前
Active immunization strategies in glioblastoma - clinical outcomes and effect modifiers for dendritic vaccines and adoptive cell therapies: a systematic review 2小时前
Micro-learning design and micro-course structuring: a systematic literature review 2小时前
Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies 2小时前
Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study 3小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com